Apovomin is effective after a single injection, with results in two to fifteen minutes.
Apovomin has the active substance apomorphine hydrochloride hemihydrate 3 mg (equivalent to apomorphine 2.56 mg). It is being marketed in 5 ml vials. It has a three-year shelf life and lasts for up to 28 days once broached.
Dechra Brand Manager Claire Morgan said: “Unfortunately there are many everyday substances that are toxic to dogs once ingested and time is of the essence when dogs have swallowed something that is poisonous to them.
“It is vital that veterinary professionals have access to a safe and effective treatment like Apovomin that they know they can rely on when dealing with cases like this.
“Apovomin offers a cost effective and successful treatment for accidental poisoning that will be an important tool for veterinary professionals in day-to-day practice.”
For more information visit www.dechra.co.uk.
The company says that despite the development of alternatives to natural bone grafting, such as allografts and synthetic products, autologous bone graft is still considered the standard. However, it has a number of disadvantages, such as donor site morbidities and lameness, limited availability of graft volume (particularly in small size pets) and additional surgical time.
Biocera-Vet is a new bone substitute indicated in surgical procedures where bone grafting is necessary, such as arthrodesis, complex fractures, corrective osteotomy used in correction of limb deformities or as add-on to Tibial Tuberosity Advancement (TTA).
Biocera-Vet is an injectable synthetic self-hardening calcium-phosphate cement combining osteo-inductive, osteo-conductive and osteo-integrative properties designed to support a fast and strong consolidation.
TheraVet says Biocera-Vet also presents an excellent safety profile thanks to its biocompatibility, reduced comorbidities and superior ergonomics which save a significant amount of surgical time.
Dr Olivier Stiévenart, an orthopaedic veterinary surgeon at Surgivet in Belgium said: "Using Biocera-Vet has enabled us to optimise our patient care considerably, by reducing the operating time by at least 30 minutes. The use of an efficient and rapid bone substitute represents a real progress in terms of both operations and the animal’s quality of life".
Julie Schurgers, Chief Commercial Officer of TheraVet, said: "Biocera-Vet is a unique product on the veterinary bone substitute market, combining outstanding bone consolidation properties with an excellent safety profile and superior ergonomics. We are very excited today to announce its commercialisation on the market and are convinced that this innovative product will significantly improve the daily practices of veterinarians, for the well-being of patients and their owners."
The product is now available in Belgium, and will be rolled out in France and the Netherlands shortly, with the rest of Europe following later in 2021 / 2022.
For more information, visit: https://www.thera.vet/en/biocera-vet.
To nominate someone for inclusion in the showcase, visit: https://www.beva.org.uk/60-Faces
BEVA President Lucy Grieve said: "We are proud of BEVA’s heritage and want to recognise our 60th birthday by celebrating some of those who have made a significant difference to the equine veterinary community. We want you to help us identify the 60 individuals who you believe have truly inspired, influenced and progressed the equine veterinary profession for the better.”
Each of the nominated 60 faces will be highlighted on the website and on BEVA’s social media channels. Profile details will include career paths, workplaces and personal contributions to the equine veterinary profession.
Lucy added: "We have already started the list with Colonel John Hickman, Sue Dyson and Peter Rossdale. But there are hundreds of exceptional, deserving individuals who have made a huge difference to the equine veterinary profession and are worthy of our 60 Faces roll call."
The deadline for nominations is Friday 16th April 2021. All nominations are anonymous.
According to the study1, which looked at Chihuahuas treated in first opinion practice, ownership in the UK has increased over five-fold in the past decade from 1.0% of all puppies born in 2005 to 5.4% in 2016.
However, the study also found the breed was particularly susceptible to a number of health issues, including: dental disease (13.5%), obesity (5.9%) and retained baby teeth (5.7%).
Compared with other dogs, Chihuahuas were also more prone to aggression (4.2%), slipping kneecap (4.0%) and retained testicles (3.9%).
Other findings included:
Dan O’Neill, senior lecturer at the RVC and author of the paper, said: "Chihuahuas are an old breed but the recent craze for them can cause some real welfare issues for this tiny dog. There is increasing evidence that unscrupulous breeders and dealers both inside and outside the UK are cashing in on this trend by making a lot of money but with little regard for the welfare of these puppies and breeding bitches."
Camilla Pegram, VetCompass epidemiologist at the RVC and co-author of the paper said: "Dental disease and retained baby teeth should be recognised as important health concerns for Chihuahuas, with preventative care for dental disease a key topic for discussion between vets and owners. In addition, many of the common or predisposed disorders, such as dental disease, retained baby teeth, sliding kneecap and retained testicle(s), often require surgical intervention. The Chihuahua’s small size increases its anaesthetic risk. Obesity has many detrimental effects, including increased anaesthetic risk, and aggression makes them challenging patients and pets, therefore nutrition, lifestyle and behaviour are also key areas for veterinary-owner discussions."
The full paper is open access: https://doi.org/10.1186/s12917-020-2258-1.
Reference:
The College says the event is aimed at RVNs who are interested in upholding standards of veterinary nursing professional conduct and who would like to help the RCVS maintain public confidence in the veterinary nursing profession. Prospective applicants for these roles should ideally have a minimum of five years' experience in veterinary nurse practice.
Attendees will have the opportunity to chat to representatives of the committee, and the staff involved in handling cases that go to disciplinary hearings. There will also be a short presentation on the application process from Thewlis Graham Associates – the external agency handling the recruitment.
RCVS staff and DC members will present some anonymised VN DC / DC example cases to talk through in small informal groups, to help convey an idea of the work involved and the challenges one could expect to face when making decisions on allegations of serious professional misconduct or fitness to practise.
The overall programme will be run in the afternoon from 3pm – 5pm and repeated in the early evening from 6pm – 8pm, to suit differing diaries and travel times. Snacks and refreshments will be provided on the day, and the RCVS will reimburse reasonable travel expenses for attendees.
Places at the information day can be reserved by contacting Deborah Rowlanes, RCVS Events Manager, via D.Rowlanes@rcvs.org.uk or 020 7202 0773. The deadline for registering is Friday 21 February 2020.
Alternatively, if you can't attend on the day itself, but would like to speak to the RCVS Registrar and Director of Legal Services Eleanor Ferguson about the vacancies, you can contact Deborah to arrange a convenient time.
Prospective committee members will then have until 5pm GMT Monday 2 March to submit their applications. Applications can be submitted through the Thewlis Graham Associates website: www.thewlisgraham.com/assignment-briefings.
The new platform offers video tutorials, podcasts, webinars, scientific studies, blogs and downloadable resources, all designed to ensure users understand how the HT Vista screening device can support their day-to-day work.
Users can also ask for a free one-on-one training call with HT Vista for personalised guidance.
HT Vista’s Managing Director, Liron Levy-Hirsch said: “We’re excited to introduce this new platform for veterinary professionals alongside our latest diagnostic update to the device.
"Our goal with HT Vista Academy is to support users in expanding their expertise, not just in operating the device but also in understanding the technology behind it and learning the best practice of dermal and subcutaneous mass management.
"By offering valuable educational resources and hands-on support, we hope to enhance the overall experience for veterinary teams and, ultimately, the care they provide to their patients.”
The company says the screening device is being widely used in nurse clinics around the world and its academy is suitable for both vets and veterinary nurses.
www.ht-vet.com/academy
According to the RVC, recent studies estimate dental disease affects up to 18% of the UK's rabbits and breeds with lop ears and short skulls (brachycephaly) have long been suspected of being more at risk.
To investigate whether there is any truth to that suspicion, a team of RVC researchers led by Maria Jackson RVN, Research Assistant in Rabbit Health and Welfare, and Dr Charlotte Burn, Associate Professor in Animal Welfare and Behaviour Science, set out to explore whether these physical features are linked to dental problems.
The study involved visual dental checks of 435 volunteered pedigree rabbits from 49 breeds at British Rabbit Council shows and breeders’ studs across the UK.
The researchers assessed tooth and mouth health using an otoscope, while also recording ear type, head shape (on a purpose-made visual scale), body size, age and sex.
The findings revealed that:
In conclusion, the study concluded that diet, environment and regular dental checks might be more important in the development of dental disease.
The researchers also concluded that any breeding decisions should be based on veterinary assessment of dental health, including otoscope or radiography examinations rather than relying solely on visual inspection of the teeth or a rabbit’s conformation.
Maria said: “Our findings add to the evidence that suggests lop ears and a brachycephalic head shape are less important in the development of dental issues in rabbits than was once thought.
"It’s clear that all rabbits, not just those with a non-wild conformation, can be affected by dental problems.
“The importance of feeding good-quality hay or grass and supplementing the diet with extruded pellets, not muesli, cannot be overstated, as diet may well be more important than conformation in the development of dental disease.
"Likewise, providing regular veterinary dental check-ups to rabbits is crucial to facilitate early dental disease detection and give case-specific dietary and treatment recommendations to slow disease progression and support the welfare of rabbits.”
Reference
Photo: depositphotos.com
The group reports that over 150 veterinary professionals have registered on its website and pledged their support.
The campaigners say they've been astonished with the response and believe the dozens of practices that have received legal letters and signed up so far could just be the tip of the iceberg.
Since the story first came to light, VetNurse.co.uk understands IVC has sent follow-up letters to a number of practices saying it has decided to offer a stay of execution and extend the deadline to comply until the 31st December 2025, before it considers taking further legal action.
However, the campaigners estimate that to rebrand so many ‘Pet Health Clubs’ will cost £250,000 and £350,000 in total, so they have now appointed an intellectual property lawyer to provide specialist advice on whether such a common term can be protected with a word mark.
Alex Green of Broadway Vets said: “Initially we set up We Are Spartacus to bring all the affected practices together to support each other, and while we’ve done this, we’ve also brought the wider veterinary community together who want to stand up to IVC Evidensia and the ridiculous word mark.
“Lots of practices have had a ‘Pet Health Club’ for more than 10 years and the majority of those that have come forward were using the term long before IVC registered its word mark in 2019, so it’s clearly an issue that people feel very passionate about, especially when it’s likely to cost each practice a significant amount of money and time to rebrand.
“We’ve been overwhelmed by the number of people who have registered to support us, especially those that aren’t affected but who want to stand shoulder to shoulder with us against such an unnecessary and underhand way of doing business.
"However, there are still several practices that are affected that we haven’t heard from, and we’d urge them to come and join us now.
“We’re also keen to hear from those that received initial letters and haven’t yet had a follow-up offering a stay of execution until the end of the year.
"Whilst we’re delighted that IVC has extended their deadline, it does not resolve the fact that their threats are unacceptable when every practice in the country provides animal, or ‘pet’, healthcare, or ‘health’, in a community-based service, or ‘club’.
“They don’t need to fight or worry about this on their own and we’re stronger as a collective, especially when it comes to pooling resources and expertise.
"We’ve already appointed a specialist IP lawyer to advise us, and the view is that given the extensive prior use of ‘Pet Health Club,’ it would be crazy to allow this to escalate to court when it can be amicably resolved.
“It’s also come to light that IVC has even registered ‘It’s not what we do, it’s why we do it’ which does rather sum it all up.
Spartacus just wants to know why IVC is doing what it’s doing.”
www.wearespartacus.co.uk
Ms Bucur MRCVS faced three charges against her.
The first charge was that in April 2024, she wrote a prescription for 60 tablets of tramadol 50mg, indicating that it was for the treatment of an animal, when it was intended for the treatment of a human.
The second charge was that she allowed the prescription to be presented at a pharmacy and/or failed to stop that.
The third charge was that her conduct, in relation to the first two charges was dishonest, and misleading, and took place in circumstances where she was not professionally qualified to write a prescription for human use.
At the outset of the hearing, Ms Bucur admitted all the charges and the Committee accepted her admissions.
In relation to charge three, the Committee found that Ms Bucur had been aware that she should not have written the prescription, that she should not have indicated that it was for an animal, that she should not have deleted the prescription for the clinical record on the practice management system, and she should not have allowed or failed to prevent the prescription from being presented for dispensing.
The Committee therefore found all charges proved.
In terms of aggravating factors, the Committee considered that Ms Bucur’s conduct had given rise to a risk of injury because she was not professionally qualified or sufficiently informed to issue a prescription for tramadol, that she had acted recklessly with regard to the potential effects of a controlled, potentially addictive drug and that her conduct had been premeditated.
It also accepted the submission that there was an abuse of Ms Bucur’s professional position as a registered veterinary surgeon, because this had allowed her to issue a prescription.
The Committee also found that Ms Bucur’s conduct was aggravated by her having involved other persons in her misconduct, namely her partner, in an attempt to have the prescription dispensed.
The Committee noted that the charges involved findings of dishonesty, which is regarded at the higher end in terms of the spectrum of gravity of misconduct.
In mitigation, the Committee took into account that the facts proved related to a single incident of the issuing and attempted use of a prescription.
The Committee was of the view that the Ms Bucur’s conduct had failed to promote protection of public health and had breached the legislation around access to controlled drugs.
Even though this was a single incident, the Committee considered that members of the public, if aware of the facts, would be alarmed and concerned at Ms Bucur’s actions.
As a result, the profession could be brought into disrepute and public confidence in the profession undermined.
The Committee therefore found that Ms Bucur’s conduct amounted to serious professional misconduct in a professional respect.
The Committee then considered whether there were any relevant additional personal aggravating or mitigating factors.
The Committee did not find any further aggravating factors; in mitigation it noted that Ms Bucur had no previous complaints of adverse matters in her career.
The Committee accepted that Ms Bucur had made early, open and frank admissions to her conduct.
She had also offered a fulsome and genuine apology and remorse in her witness statement and in the hearing.
The Committee also accepted that she had since worked without further incident and concluded from her witness statement and evidence that she had developed full insight into her misconduct.
She was able to provide a notable number of references and testimonials which were uniform in speaking to her positive qualities as a veterinary surgeon.
The Committee was able to conclude that this has been a very serious but single lapse of judgement, and that there was a relevant context in that Ms Bucur had clearly acted out of concerns to help her father, however misguided.
There were no suggestions of harm, or risk of harm, to animals.
However, the Committee could not ignore that Ms Bucur’s misconduct had occurred in relation to a controlled drug and had contravened important protections designed to protect the public.
Neil Slater, chairing the Committee and speaking on its behalf, said: “The Committee balanced the effect that a suspension would have on Dr Bucur, by depriving her of the ability to practise for a period, with the public interest.
"However, it decided that, in the circumstances, the interests of protecting the public, including the wider public interest, outweighed Dr Bucur’s interests.
“The Committee decided that, in all the circumstances, a suspension was the appropriate and proportionate sanction.
“The Committee considered for how long the suspension should be imposed.
"It considered that the suspension was not required to allow for Dr Bucur to gain any further insight.
"It would purely be required to mark the Committee’s disapproval of Dr Bucur’s misconduct, as a signal to the public and to the profession.
"The Committee concluded that the least period required in all the circumstances is two months.
“The Committee therefore directed to the Registrar that Dr Bucur’s registration be suspended for a period of two months.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Dogs with RVED develop retinal degeneration from around four years of age which, if untreated, leads to blindness.
In partnership with James Oliver, Head of Ophthalmology at DWR Veterinary Specialists (pictured), researchers set out to discover why some Cocker Spaniels have such low vitamin E levels in their blood, despite it being present at normal amounts in their diet
James helped to design the study, recruit cases and collect samples.
Cathryn Mellersh, Senior Research Associate at the Canine Genetics Centre, said: “The team strongly suspected a genetic cause and has been trying to discover the responsible gene for several years with the help of owners and vets, who have contributed DNA samples.
“Thanks to updated information on the canine genome, Katherine Stanbury, one of our research associates, found a mutation in the alpha tocopherol transfer protein gene which is causative of the disease.
“This gene is responsible for getting vitamin E into the blood stream.
"We now know that RVED is a recessive disease, meaning that affected dogs must have two copies of the faulty gene to develop low vitamin E levels and retinal degeneration.”
The team’s DNA test can be used by dog breeders to find out if dogs carry the gene mutation, so they can avoid matings which result in affected puppies being born.
Cathryn said: “This DNA test is a rare example of one which not only can be used to identify dogs that are carrying the mutation and thus reduce the frequency of the mutation in future generations, but also has the incredible benefit of providing a sight-saving treatment option for dogs with the disease.
“From the research we have done we estimate that there could be several hundred Cocker Spaniels alive today that have two copies of this mutation, whose eyesight could be saved by this test.”
A DNA test for the mutation that causes RVED is now available from Canine Genetics Testing, which operates alongside researchers from the Canine Genetics Centre.
www.cagt.co.uk.
The team’s RVED research can be viewed at https://academic.oup.com/g3journal/advance-article/doi/10.1093/g3journal/jkaf016/7985679?searchresult=1
The grants, which are for up to £3,500 per annum, are for students - often from disadvantaged backgrounds - who are embarking on a gateway or main veterinary degree course, possibly as a second degree.
Quadstar's latest grantees are Alicia Guarnieri, who is doing a vet degree at the University of Bristol, and Raluca Magadan, a veterinary nurse from Ireland, who is now on the accelerated graduate course at Bristol University.
She said: “Doing a second degree was never going to be easy.
"However, through help from family and locum vet nurse work, I managed to afford my first three years of vet school and made it into final year.
"This is where the difficulty came, as I had to more than forty hours per week of unpaid rotations work, plus clinical EMS during the holiday breaks, which made it very hard for me to earn the money I needed to afford my final year.
"At times it meant I had under £100 to survive an entire month on, which became a big physical and mental challenge.
“That’s when the Quadstar Foundation stepped in and took a weight off my shoulders by helping to pay off my outstanding university fees and providing some financial security in my final months.
"This has been a huge relief and allowed me to finally enjoy my last year at Bristol.
"I can’t thank everyone at the charity enough.”
In addition to funding and mentoring, The Quadstar Foundation helps its grantees with everything from job applications to revision techniques, as well as any mental health crises and helping them to find a place to live.
Nick, who also runs a property and acquisitions company and Animus Surgical, a pet and vet supplies company, said: “Having worked as a vet for many years before setting up my businesses, I have great industry connections and knowledge.
"So, I’m in the privileged position of being able to help committed students to seize the career opportunities they deserve.”
“My main commercial motivation now is to be able to maintain the funding streams required for these grants.
"It’s surprisingly hard to fundraise for individuals.
"That’s why Animus Surgical has just committed to donating 15% of its profits to the Quadstar Foundation.”
He added: “It’s an enormous privilege to support these inspiring young vets who have had such a hard slog to get past the ever-increasing barriers they face. Barriers that back in our day didn’t exist.”
www.quadstar.org
Anyone - clients, colleagues or mentors - can nominate a young vet who they think has exceptional clinical skills, a particular passion for equine welfare or great leadership skills.
To be eligible nominees need to be members of BEVA, have graduated within the past seven years and be a registered professional with the appropriate body (eg RCVS).
BEVA Council Member Gemma Dransfield said: “We all know that one superstar who's brilliant with patients, fantastic with clients, and just an all-round legend in the making."
“This is your chance to give them the recognition they deserve.
"The BEVA One To Watch Award recognises those who are shaping the future, setting new standards in equine care, and driving the next generation of equine veterinary excellence.
"Not only will they have the glowing accolade of winning, but they will also win some career-boosting perks.”
To put an individual forward for consideration, a seconder is needed and either the nominator or seconder must be a BEVA member.
All nominations will be reviewed by a panel of experts comprising a BEVA Careers Committee representative, a senior equine vet, a non-equine veterinary professional and an external industry representative or client.
Up to five finalists will be selected and invited for a friendly online chat with the judging panel.
The winner will be announced at BEVA Congress and will be presented with a trophy, one year of BEVA membership, a fully paid BEVA Congress experience (including a one-day pass, overnight stay, and ticket to the annual dinner) and an exclusive career-boosting opportunities with BEVA to help take their career to the next level.
All finalists will receive a one-day ticket to BEVA Congress.
www.beva.org.uk/About-us/What-we-do/BEVA-Awards/One-to-watch
The Swadlincote and Melbourne-based IVC practice worked with a Great Workplaces by BVA accreditor during the pilot of the new scheme, to demonstrate its strengths against an accreditation framework covering four key themes: health and wellbeing, leadership and management, culture and learning and development.
In the report, the accreditor was particularly impressed by the practice’s strong leadership and management; its emphasis on accommodating flexibility for team members in various forms; a robust teamworking ethos; and a focus on continuous improvement.
British Veterinary Association President Elizabeth Mullineaux said: “We’re delighted to see Swadlincote Veterinary Centre become the first veterinary workplace to achieve Gold accreditation through Great Workplaces by BVA scheme.
"Congratulations to the whole practice team for this incredible recognition.
“Creating positive working environments and targeting areas for improvement are the key to tackling ongoing workforce challenges around recruitment and retention.
"We hope this first Gold accreditation inspires others to strive towards gaining recognition as workplaces where vet teams thrive.”
Ingrid Stevenson, Clinical Director at Swadlincote Veterinary Centre, said: “While we knew the practice was doing well, we didn’t go into this process expecting Gold at all.
"My practice manager and I were just both really keen to get some feedback and to find out what more we could do to help the team.
“We have several clinical accreditations in the practice, but it is the team that are responsible for achieving these and maintaining the high standards.
"I believe the team should be looked after, recognised and rewarded for their hard work and going above and beyond when necessary.
"The team were really pleased when I shared the news.
"It has certainly been good for team morale and a positive outcome to share with potential new recruits. '
“The accreditation process was a thorough assessment of the practice and our accreditor made us feel all at ease during the interviews.
"While we achieved Gold, which was unexpected, we have also learnt of areas to develop further over the coming months.
"Overall, it was a positive experience for our practice.”
www.bva.co.uk/take-action/good-veterinary-workplaces/
The one-hours session: "How do you recommend parasite treatments to your clients?" will be presented by Zoetis Veterinary Consultant Ruth Moxon MVB MRCVS.
Ruth will discuss how to structure advice and how to take the conversation away from the idea of ‘selling’ and towards a confident recommendation based on the pet’s needs.
The course will cover:
Ruth said: “We are aiming for attendees to leave the session feeling confident about discussing recommendations to clients on parasiticides.
"The talk will enable them to comfortably explain the features and benefits of the right parasiticide for that pet and owner in an objective way.”
The course is free to BVNA members.
Non-members are welcome to join the webinar at a cost of £15.00 per ticket.
To book, email: cpd@bvna.co.uk
Photo: BVNA
The webinars will be available as live podcasts and will also be able to be viewed on demand on the Dechra Academy.
In the strangles webinar, Dave Rendle, Gayle Hallowell and Richard Newton will explore the current landscape of strangles control, focusing on the role of vaccination, testing and quarantine measures.
In the disease prevention webinar, Gayle Hallowell, Dave Rendle, Tamzin Furtado and others will give an insight into chronic disease management and preventative vaccination to improve uptake and optimise treatment outcomes.
Both webinars broadcast from 8pm GMT, with a live Q&A session from 8:45pm, finishing at 9:15pm.
https://membership.elearning.vet/Dechra-equine-medicine-series.
There are a mix of online and in-person events.
On the 27th February at 7:00pm, Derek Flaherty, Professor in Veterinary Anaesthesia and Analgesia will cover common complications with veterinary anaesthesia and how you can deal with them during this in person event.
On the 29th April and 30th September, Tobi Wagner, Head of Cardiology at Southern Counties (pictured), will test your echo interpretation skills in an interactive online webinar.
On the 11th March, 1st July and 11th November, Tobi will be hosting Echo Clinics: small-group four-hour practical sessions which will look at how to obtain the necessary echocardiography views that can aid decision making in day-to-day clinical practice. Echo Clinics cost £375.
For nurses specifically, Katie Foley and Tom Chapman will be hosting an in-person session looking at suture techniques on Thursday 6th February.
https://www.scvetspecialists.co.uk/vet-professionals/cpd
The overview starts with the CMA noting how it has had significant dealings with many vets and nurses from different practices and acknowledging their dedication and commitment to owners and their animals.
Nevertheless, the CMA has identified various areas of concern about the state of the marketplace:
The CMA says it will publish three further papers in the spring, one sharing its analysis of treatment and pricing data from two large insurance companies, another in which it will lay out its proposed remedies to the concerns it has raised, and a final one analysing the profitability of veterinary businesses.
https://www.gov.uk/cma-cases/veterinary-services-market-for-pets-review#working-papers
The initiative seeks to understand the barriers and enablers to delivering contextualised care in companion animal practices, and to set out what contextualised care looks like when done well.
As part of the initiative, RCVS Knowledge is gathering perspectives from across the veterinary community and from pet owners to design a roadmap for the profession.
The work started last week at the National Forum for Contextualised Care in London, which brought together more than 60 people from across the veterinary sector, including leaders from veterinary associations, veterinary educators, students, practice staff, veterinary charities and rescues, pet insurers, regulators, representatives from corporate and independent practices and animal owners.
RCVS Knowledge will now be working with an independent research partner to conduct focus groups, surveys and interviews to gather a representative range of views from across the sector and pet owners.
The work will culminate in a summit in the summer that will use the findings of the research to design recommendations on:
Sally Everitt, Clinical Lead – Evidence at RCVS Knowledge said: “Contextualised care is the way of delivering veterinary care that acknowledges that there are different ways to approach the diagnosis and treatment of an animal, depending on the circumstances of the individual animal and their caregivers and the context in which the care is delivered.
"The term has been used increasingly over the past year, and is now the subject of much debate, alongside other aligned terms such as ‘spectrum of care’ and ‘pragmatic medicine’.
"However, we need to better understand what constitutes good-quality contextualised care, and the barriers and enablers to its delivery in practice.”
Katie Mantell, Chief Executive of RCVS Knowledge, said: “As an independent charity with a mission to advance the quality of veterinary care, we believe RCVS Knowledge is well-placed to bring together all parts of the veterinary community to seek consensus on what good-quality contextualised care looks like and how it can be delivered in practice.
"Our aim is to take a collaborative, robust approach to co-producing a roadmap for contextualised care that will support its widespread delivery for the benefit of animals, the veterinary professions and animal owners.”
To be updated about the progress of this work, and to hear about opportunities to take part in the focus groups, interviews and surveys to follow, sign up to receive RCVS Knowledge’s monthly email newsletter intheKNOW.
"Reasons to be fearful? Rising proportions of positive faecal worm egg counts among UK horses (2007–2023)1" which was conducted in collaboration with Animal Health Vision International, the University of Liverpool and jDATA Pty (Ltd), analysed quarterly surveillance data summaries of FWEC test results that were submitted to the Equine Quarterly Disease Surveillance report (EQDSR) by 36 UK laboratories.
Of these, 18 laboratories provided additional details through a survey on the testing methods adopted.
The researchers say there was considerable variation between laboratories in both the FWEC test methods used and the FWEC positivity thresholds applied to designate a test result as positive for either surveillance reporting or for treatment purposes.
However, the analysis revealed an increase in the proportion of positive FWECs over time, even after accounting for the time of year that testing was conducted, the FWEC positivity threshold used for reporting a sample as positive and the laboratory undertaking the testing.
Researchers say these findings raise questions about targeted treatment strategies, where anthelmintics are administered if FWECs exceed a certain threshold.
If this threshold remains low, the increasing proportion of positive FWECs that were identified would lead to increased use of wormers, potentially accelerating the development of anthelmintic resistance.
This highlights the need to better understand the factors driving rising FWEC positivity rates and if they are a cause for concern.
For example, is this trend leading to increased numbers of horses exceeding the treatment threshold and therefore being recommended for treatment?
The study authors say that the continuation of coordinated efforts to enhance parasite control strategies across the UK equine industry is essential.
The recently available guidelines from the British Equine Veterinary Association (BEVA) and CANTER provide essential resources for vets, pharmacists and RAMAs/SQPs who prescribe equine anthelmintics to optimise parasite control2,3.
References
The survey of 76 vets and nurses, which was conducted by the company in September and October 2024, found that 43% believe that staff wellbeing could be improved within their practice.
It also found that 93% agreed it is important for staff wellbeing to be taken seriously (Ed's note: one wonders what the other 7% think).
The most common strategies were:
NVS, which also sells a range of natural calming products for animals including NVS Select Calming Chews, also asked veterinary professionals how often they encounter nervous or stressed animals.
The answer from 92% of respondents was, perhaps a little unsurprisingly, daily.
82% said they use medications and supplements to support nervous animals.
https://www.nvsweb.co.uk/products/big-chill/
https://www.nvsweb.co.uk/our-brands/select-from-nvs
The company says AI Masses will allow veterinary professionals to analyse lesions suggestive of cancer in-clinic and with a fast turnaround.
The AI technology, which has been trained by human clinical pathologists, should enable individualised treatment outcomes earlier for more cases.
Zoetis says AI Masses only needs a single round of sample preparation and the results can, at additional cost, be supplemented with an expert review from a network of specialists through Zoetis’ Virtual Laboratory.
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer at Zoetis said: “Waiting for results can be stressful for pet owners – even more so when it involves a cancer screening.
"Our research shows that up to 75% of pet owners find abnormal results highly stressful.1
"AI Masses is yet another point-of-care capability to deliver results in-clinic, further exemplifies Zoetis’ purpose to advance care for animals, shortening anxious wait times to allow for faster care decisions that help provide the best possible outcome.”
Pre-orders will be announced for US customers in Q2 2025.
VetSurgeon.org understands AI Masses will be coming to the UK some time in 2025.
https://www.zoetisdiagnostics.com
The RCVS says this is the first time that two leading organisations in veterinary QI are collaborating to establish a new evidence-based model for QI specific to veterinary care.
The project is being overseen by Jocelyn Toner MRCVS, an experienced veterinary surgeon with a background in shelter medicine and an interest in evidence-based interventions to improve welfare outcomes.
The team will test the model against a prevalent problem in practice and measure the cost of making the changes against the benefit it brings.
They will refine the model based on lessons learned before they make it available to all veterinary practices, to tackle any area a practice wants to improve, regardless of practice type or specialism.
The aim is to help time-poor practitioners implement proven QI methods to improve outcomes and provide a return on investment.
Jocelyn said: “I’m looking forward to working with colleagues from across the sector to develop a model that will make Quality Improvement more accessible, and show that it can have a real economic benefit.
"We know that there is increased demand for veterinary teams to provide more efficient and effective care while maintaining high levels of animal welfare, improving team welfare and client satisfaction.
"Over recent years an increasing number of veterinary teams have embraced QI techniques.
"Now is the time to take this to the next level by creating an evidence-based model for QI, which can be applied systematically in any veterinary setting.
The project will involve bringing together veterinary professionals to co-design the model and test it in practice.
If you are interested in supporting this work, please register your interest at: rcvsknowledge.org.uk/forms/ktp-interest-form/